Urging The Hawaii Congressional Delegation And State Officials To Support The Marijuana In Federally Assisted Housing Parity Act Of 2021 And Requesting Assistance From The Drug Enforcement Administration To Resolve The Conflict Between The Federal Regulation Of Marijuana And State-authorized Use Of Cannabis In Hawaii.
If enacted, SCR51 would empower Hawaii's congressional representatives to advocate for the passage of H.R. No. 3212, which would allow the use of cannabis in federally assisted housing facilities in accordance with state laws. The resolution emphasizes the importance of resolving the conflicting regulations that currently hinder patients' rights to use cannabis legally in Hawaii while living in federally subsidized housing. By calling upon local and federal officials to take action, SCR51 aims to mitigate the adverse effects faced by medical cannabis patients due to bureaucratic obstacles.
SCR51 is a Senate Concurrent Resolution urging Hawaii's congressional delegation and state officials to support the Marijuana in Federally Assisted Housing Parity Act of 2021. The resolution highlights the ongoing conflict between state laws governing the use of cannabis for medical purposes and federal regulations, which can lead to detrimental consequences for registered medical cannabis patients in Hawaii, including evictions from federally subsidized housing. SCR51 seeks to address these issues by requesting that authorities, particularly the Drug Enforcement Administration (DEA), assist in aligning federal regulations with state-sanctioned cannabis use.
The resolution reflects a strong legislative consensus on the need to resolve the disparities between federal and state cannabis laws. While some lawmakers see this as a necessary step in protecting the rights and wellbeing of medical cannabis patients, concerns may arise regarding the potential implications for housing policy and drug enforcement at the federal level. Advocates argue for the importance of addressing these issues to prevent unlawful evictions, while critics may worry about the broader ramifications of relaxing federal restrictions on cannabis use in federally funded programs.